Oppenheimer Asset Management’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-13,901
Closed -$350K 1131
2022
Q2
$350K Sell
13,901
-3,577
-20% -$107K 0.01% 945
2022
Q1
$631K Sell
17,478
-14,526
-45% -$715K 0.01% 864
2021
Q4
$2.45M Buy
32,004
+158
+0.5% +$13.9K 0.03% 489
2021
Q3
$3.06M Sell
31,846
-5,334
-14% -$582K 0.04% 399
2021
Q2
$3.97M Buy
37,180
+5,086
+16% +$501K 0.06% 349
2021
Q1
$2.88M Buy
32,094
+2,115
+7% +$233K 0.04% 414
2020
Q4
$3.01M Buy
29,979
+665
+2% +$49.6K 0.05% 374
2020
Q3
$1.43M Buy
29,314
+11,240
+62% +$540K 0.03% 513
2020
Q2
$739K Buy
18,074
+15,765
+683% +$453K 0.02% 680
2020
Q1
$36K Sell
2,309
-91
-4% -$1.91K ﹤0.01% 1302
2019
Q4
$54K Buy
+2,400
New +$39.4K ﹤0.01% 1326

Other funds holding CRNC

Oppenheimer Asset Management's CRNC Position: Q3 2022 in Review

Oppenheimer Asset Management sold out of Cerence (CRNC) in Q3 2022, closing a stake of 13,901 shares — an estimated $350K sold.

Oppenheimer Asset Management first reported a position in CRNC in Q4 2019 and held it in 11 quarters. The position peaked at $3.97M in Q2 2021. 230 funds tracked by Wall St. Rank hold CRNC as of Q3 2022.

  • Oppenheimer Asset Management reported no remaining Cerence position as of Q3 2022 after selling out during the quarter.
  • Oppenheimer Asset Management sold 13,901 Cerence shares in Q3 2022, an estimated $350K.
  • Oppenheimer Asset Management first reported a position in Cerence in Q4 2019 and held it in 11 quarters.
  • Oppenheimer Asset Management's Cerence position peaked at $3.97M in Q2 2021.
  • 230 funds tracked by Wall St. Rank held Cerence as of Q3 2022.

Based on Oppenheimer Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.